in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Pharma/fine chemicals roundup—6 August 2013
5:02 AM MDT | August 6, 2013 | Deepti Ramesh
Teva’s API business reports fall in sales The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 9.5% fall in sales in the second quarter of 2013, compared with the year-ago period, to $181 million. For the six-month period ended 30 June, the API business reports an 8% fall in sales, compared with the first six months of 2012, to $367 million. Teva has the largest API business in the world in terms of sales. API business of Dr. Reddy’s reports rise in sales The pharmaceutical services...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee